Searched for
PHARMACEUTICAL COMPANIES
Drug cos refuse to take sole responsibility for overpricingIndian drugmakers oppose a proposal making them solely liable for medicine overpricing. This regulatory move exempts retail chemists, hospi...- Cohance Lifesciences to invest USD 18 mn in NJ Bio, Aruka BioCohance Lifesciences announced an eighteen million dollar investment to strengthen its antibody-drug conjugate strategy. This includes thir...
- Gland Pharma shares: Promoter Fosun Pharma likely to divest 5% equity worth Rs 2,279 crore via block dealFosun Pharma plans to divest 5% equity in Gland Pharma through a Rs 2,279.5 crore block deal at Rs 2,763 per share. Gland Pharma reported a...
- Prasol Chemicals fixes price band for Rs 500-cr IPO; issue to open on Sep 8Prasol Chemicals will launch its Rs 500-crore Initial Public Offering on September 8. The company has fixed the price band at Rs 643-676 pe...
- Chips won't taste good unless made in USPresident Donald Trump already imposed 25% tariffs on certain advanced semiconductors, ordering those import charges in January after a Com...
- Tough task: Staying invested in businesses while ignoring noise called Gulf war; 6 mid-cap stocks with upside potential of up to 23%Trying to time the market turns volatility into something that beats an investor twice: Once on the way down, and once on the way up. So, i...
- Sun Pharma agrees to lower US drug prices under Trump plan; analysts see limited financial impactSun Pharmaceutical Industries will offer its drugs at prices matching other developed nations. This agreement aims to make healthcare affor...
- Permira to buy 25.71% in Cloudnine Hospitals parent: CCI filingPermira, a leading global private equity firm, is ready to buy a significant stake in Cloudnine Hospitals, which places the parent company'...
- Oncology firm Novocure says cyberattack exposed US patient recordsThe breach adds to a growing number of cyberattacks on the healthcare sector, including medical device makers Abbott, Stryker Medtronic a...
- Sun Pharma to extend MFN pricing to US state Medicaid programmesSun Pharma ranks second in US dermatology by prescriptions, with key brands including Ilumya for plaque psoriasis and Winlevi for acne. Rec...
- Symbiotec Pharmalab shares list at 1% discount to IPO priceThe Symbiotec Pharmalab IPO plans to channel Rs 112.50 crore towards the prepayment and/or repayment, fully or partially, of select outstan...
- Sun Pharma among 9 pharmaceutical firms to lower drug prices for Americans, Trump saysNine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of co...
- Mankind Pharma divests entire stake in Broadway Hospitality to AKRK ProjectsMankind Pharma has completed the sale of its entire stake in Broadway Hospitality Services. The transaction involved transferring 100 perce...
- Aurobindo Pharma gains over 3% as subsidiary launches generic Advair Diskus in US; stock up 41% YTDAurobindo Pharma shares rose sharply after its subsidiary Lannett Company launched the generic equivalent of Advair Diskus in the US. The i...
- India seeks easier pharma access in Brazil, pushes to expand Mercosur trade pactIndia seeks predictable regulations and easier market access for its pharmaceutical products. Discussions occurred at the India-Brazil Trad...
- Argentina to ease pharma barriers as India trade tops $6.5 bnArgentina committed to reducing barriers for Indian pharmaceutical entry. This move will offer greater opportunities for Indian companies a...
- Huawei plans for more AI pharma tie-ups, says healthcare presidentThe move highlights Huawei's ambitions to gain a foothold in the fast-growing AI drug discovery market, where pharmaceutical companies are ...
- White House to announce new drug pricing deals with biotechs: ReportThe Trump administration is expected to announce voluntary drug-pricing agreements with midsize biotech companies, requiring discounts for ...
- DRL, Emcure get approval to make breakthrough HIV drugIndia's drug regulator has cleared the path for local lenacapavir manufacturing. Two Indian pharmaceutical companies received waivers for l...
- USFDA ends inspection of Aurobindo Pharma arm's facility with 4 observationsAurobindo Pharma announced its subsidiary Lannett Company LLC's facility inspection concluded. The US Food and Drug Administration conducte...
Load More
